BioCentury
ARTICLE | Clinical News

Revlimid lenalidomide: Additional Phase III data

June 8, 2009 7:00 AM UTC

Combined data from 353 patients enrolled in the Phase III MM-009 and MM-010 trials showed that a subgroup of patients who received Revlimid plus dexamethasone at first relapse had a significantly impr...